Cargando…

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors

BACKGROUND: The BNT162b2 vaccine conferred 95% protection against COVID-19 in people aged 16 years or older. OBJECTIVE: The aim of this observational study was to evaluate safety and efficacy of vaccine in patients affected by primary brain tumor (PBT). METHODS: We proposed COVID-19 vaccine to all p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanzilli, Antonio, Pace, Andrea, Ciliberto, Gennaro, La Malfa, Antonia Marina, Buonomo, Valentina, Benincasa, Dario, Biscu, Annamaria, Galiè, Edvina, Villani, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994182/ https://www.ncbi.nlm.nih.gov/pubmed/35397014 http://dx.doi.org/10.1007/s10072-022-06054-3

Ejemplares similares

Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
por: Saito, Kazuyuki, et al.
Publicado: (2021)

Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination
por: Fotiadou, Aggeliki, et al.
Publicado: (2022)

Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
por: Trimboli, Michele, et al.
Publicado: (2021)

Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders
por: Sauerwein, Kai M.T., et al.
Publicado: (2023)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2
por: Umezawa, Shu, et al.
Publicado: (2022)

Guillain–Barré syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea
por: Kim, Namkyun, et al.
Publicado: (2022)

Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021)

Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis following third dose of BNT162b2 COVID-19 vaccine in a patient with systemic lupus erythematosus
por: Kang, Minsung, et al.
Publicado: (2023)

Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study
por: Kang, Yu Min, et al.
Publicado: (2021)

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
por: Harrington, Patrick, et al.
Publicado: (2021)

Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
por: Kerr, Steven, et al.
Publicado: (2022)

Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa
por: Iannone, Michela, et al.
Publicado: (2021)

Herpes zoster and alopecia areata following mRNA BNT162b2 COVID‐19 vaccine: Controversial immune effects
por: Martora, Fabrizio, et al.
Publicado: (2022)

Does ChAdOx1-S and BNT162b2 heterologous prime-boost vaccination trigger higher rates of vaccine-related adverse events?
por: Haji, Alhan, et al.
Publicado: (2023)

The Association Between Symptoms and COVID-19 Test Results Among Healthcare Workers
por: Sacks, Chana A., et al.
Publicado: (2020)

The impact of COVID-19 on shoulder and elbow trauma in a skeletally immature population: an Italian survey
por: Gumina, Stefano, et al.
Publicado: (2020)

The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach
por: Villani, Veronica, et al.
Publicado: (2023)

Linking Staff Cases in a Hospital COVID-19 Outbreak Using Electronic Tracking Data
por: Dhaubhadel, Pragya, et al.
Publicado: (2021)

New-onset anosmia and taste distortion: see beyond COVID-19
por: Casciato, Sara, et al.
Publicado: (2020)

Predictors of self-perceived health worsening over COVID-19 emergency in ALS
por: Cabona, Corrado, et al.
Publicado: (2021)

Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia
por: Pimpinelli, Fulvia, et al.
Publicado: (2021)

Quadriparesis caused by retropharyngeal and epidural abscess in COVID-19 patients
por: Gennaro, Nicolò, et al.
Publicado: (2021)

The value of EEG attenuation in the prediction of outcome in COVID-19 patients
por: Marinelli, Lucio, et al.
Publicado: (2022)

Brain microvascular occlusive disorder in COVID-19: a case report
por: Saitta, Laura, et al.
Publicado: (2020)

Italian nurses' COVID-19 experiences from mass media interviews: a qualitative study
por: ZANINI, MILKO, et al.
Publicado: (2022)

A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2
por: Schroeder, Jan Walter, et al.
Publicado: (2022)

Selective cranial multineuritis in severe COVID-19 pneumonia: two cases and literature review
por: De Gennaro, R., et al.
Publicado: (2021)

Impact of COVID-19 pandemic on Italian Otolaryngology Units: a nationwide study
por: Mannelli, Giuditta, et al.
Publicado: (2020)

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
por: Affinito, Giuseppina, et al.
Publicado: (2023)

Wound Care during COVID-19 Pandemic
por: Tinelli, Giovanni, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on paediatric otolaryngology: a nationwide study
por: Trecca, Eleonora M.C., et al.
Publicado: (2023)

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
por: Risma, Kimberly A., et al.
Publicado: (2021)

Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination
por: Yagi, Yohsuke, et al.
Publicado: (2021)

Clinicopathological features of cutaneous reactions after mRNA‐based COVID‐19 vaccines
por: Tihy, M., et al.
Publicado: (2021)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2022)

Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)
por: Dubbioso, Raffaele, et al.
Publicado: (2020)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination
por: Miyamoto, Katsuichi, et al.
Publicado: (2022)

Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report
por: Luciani, Michelangelo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kd224hk0ol7ffdqaba13bf3845